埃索美拉唑

埃索美拉唑根除幽门螺杆菌的Meta分析

Esomeprazole in Eradicating Helicobacter Pylori : A Meta-Analysis

H.pylori阴性组病人随机分成2个亚组，分别给予埃索美拉唑镁（C组）和替普瑞酮（D组）治疗。

H.pylori-negative group was randomly divided into two subgroups , patients of these two subgroups were treated with esomeprazole or teprenone seperately .

目的：观察埃索美拉唑短程三联疗法根除幽门螺杆菌（Hp）及治疗十二指肠溃疡的效果。

Objective : to assess the effect of esomeprazole-based triple therapy on healing of duodenal ulcer with Helicobacter pylori infection .

结论埃索美拉唑三联1周疗法在十二指肠球部溃疡病人中有很高的HP根除率和溃疡愈合率。

Conclusions Esomeprazole-based triple therapy one week in the patient of duodenal ulcer have highly eradication rate of Hp and ulcer healing rate .

A组：埃索美拉唑40mg每日1次；

Group A : esomeprazole of 40 mg , once daily ;

结论埃索美拉唑三联疗法治疗Hp阳性的十二指肠溃疡安全有效，腹痛缓解速度优于奥美拉唑三联疗法。

Conclusion Esomeprazole-based triple therapy may effectively eradicate Hp infection and promote duodenal ulcer healing with good tolerance , capable of achieving more speedy pain relief than omeprazole-based therapy .

埃索美拉唑联合莫沙比利治疗老年低压型LES食管运动功能障碍29例

Effect of esomeprazole and mosapride on the esophageal motility dysfunction in elderly patients with hypotensive LES : an analysis of 29 cases

结论对于NERD患者，埃索美拉唑20mg与莫沙比利联用可能为最经济有效地选择之一。

Conclusion Esomeprazole Of 2 mg plus mosapride is perhaps one of the most cost effective therapies for NERD patients .

背景：阿司匹林及氯吡格雷联合抗血小板治疗在世界范围内广泛运用，而质子泵抑制剂（PPI）包括埃索美拉唑及泮托拉唑是临床上最常用于防止胃肠道出血的药物之一。

Background : Aspirin-clopidogrel antiplatelet dual therapy is prescribed worldwide , with PPIs included esomeprazole and pantoprazole were frequently associated to prevent gastrointestinal bleeding .

现在，FDA的初步结论是，总体而言，这些资料不能证实使用奥美拉唑或埃索美拉唑的患者会增加心脏问题风险。

At this time , FDA 's preliminary conclusion is that collectively , these data do not suggest an increased risk of heart problems for patients treated with omeprazole or esomeprazole .

埃索美拉唑组和奥美拉唑组溃疡愈合率分别为92.3%和88.5%，Hp根除率分别为88.5%和82.7%，差异无显著性（P>0.05）。

Ulcer healing rate and Hp eradication rate were 92.3 % and 88.5 % in group A , and 88.5 % and 82.7 % in group B , showing no significant differences between the two groups ( P > 0.05 ) .

溃疡的愈合率和HP清除率，与奥美拉唑组70%和60%相比（P<0.01），埃索美拉唑组分别为95.8%和91.7%。

The recovery rate and cleaning rate of Hp were 95.8 % and 91.7 % respectively in Group I and 70 % and 60 % in Group II , There were significant difference between 2 groups ( p < 0.01 ) .

结果埃索美拉唑组第1天和第2天腹痛缓解率分别为34.6%和59.6%，高于奥美拉唑组的17.3%和38.5%（P0.05）。

Results On the first and second days of medication , the abdominal pain relief rates were 34.6 % and 59.6 % respectively in group A , significantly higher than those in group B ( 17.3 % and 38.5 % , respectively , P0.05 ) .

结论未观察到CYP2C19基因多态性对埃索美拉唑的抑酸效应的影响。

Conclusion We did not find the difference between the two CYP2C19 phenotypes in relation to the acid-suppressing effect of esomeprazole .

目的观察埃索美拉唑（商品名：耐信）和氟哌噻吨美利曲辛（商品名：黛力新）治疗伴有抑郁或焦虑的非糜烂性胃食管反流病（NERD）的疗效。

Objective To investigate the efficacy of esomeprazole ( Esomeprazole ) and flupentixol and melitracen ( Deanxit ) in treatment of non-erosive gastroesophageal reflux disease ( NERD ) with depression and anxiety .

埃索美拉唑在幽门螺杆菌阳性的十二指肠溃疡中的治疗效果

Therapeutic Efficacy of Esomeprazole on Duodenal Ulcer patients with Helicobacter Pylori

埃索美拉唑三联疗法根除幽门螺杆菌感染

Esomeprazole based triple therapy for the eradication of helicobacter pylori infection

埃索美拉唑在应用非甾体抗炎药患者中的预防作用

Preventive Effect of Esomeprazole on Non-steroidal Anti-inflammatory Drugs-induced Peptic Ulcer

埃索美拉唑联合曲美布汀治疗非糜烂性反流病的临床疗效

Effects of esomeprazole combined with trimebutine in treatment for nonerosive reflux disease

埃索美拉唑治疗裂孔疝并发食管炎的临床观察

Clinical Observation of Esomeprazole for Reflux Esophagitis Complicated by Esophageal Hiatal Hernia

178例老年人消化性溃疡临床特征及埃索美拉唑疗效观察

Clinical research on esomeprazole in the treatment of peptic ulcer in elderly

埃索美拉唑治疗难治性十二指肠球部溃疡的临床疗效观察

Clinical therapeutical effect of esomeprazole in the treatment of resistant duodenal ulcer

含左氧氟沙星、埃索美拉唑的三联方案治疗幽门螺旋杆菌的初步探讨

Primary Discussion of Esomeprazole Plus Levofloxacin and Amoxicillin in Treatment of Helicobacter pylori

埃索美拉唑治疗小儿胃食管反流临床观察

Clinical observation of esomeprazole therapy for gastro - oesophageal reflux disease in children

埃索美拉唑联合多潘立酮治疗反流性食管炎疗效观察

Effect of esomeprazole combined with domperidone on reflux esophagitis

埃索美拉唑治疗反流性咳嗽的疗效分析

Clinical effect of esomeprazole on gastroesophageal reflux induced cough

埃索美拉唑治疗难治性胃食管反流病的临床观察

Treatment of refractory gastroesophageal reflux disease by esomeprazole

埃索美拉唑治疗幽门螺旋杆菌相关性消化性溃疡

Treating Hp - related digestive ulcer with esomeprazole

埃索美拉唑与奥美拉唑三联疗法治疗十二指肠球部溃疡的成本&效果分析

Cost-effectiveness analysis of esomeprazole-based and omeprazole-based triple therapeutic schemes for duodenal ball department ulcer

左氧氟沙星联合阿莫西林、埃索美拉唑方案根除幽门螺杆菌疗效观察

Therapeutic effect of trilogy eradicates helicobacter pylori infection with esomeprazole , levofloxacin and amoxicillin